Investigational Site Number : 6430008

Tyumen 625000

0 studies enrolling now · 1 studies all time

What they study most

Multiple Sclerosis

Studies at this site

• Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple Sclerosis — Running, not enrolling